Background Inhibitor of growth 1b (ING1b) is considered to be a class II tumor suppressor gene. Although reduced expression of p33
Introduction
Over the past few decades, substantial progress has been made in defining potential molecular pathways in carcinogenesis and identifying many new potential therapeutic targets. Molecular mechanisms underlying carcinogenesis involve abnormalities of oncogenes, tumor suppressor genes (TSGs), cell adhesion molecules, cell cycle regulators, DNA repair, genetic instability, and growth factors and cytokines. Inhibition of growth 1 (ING1), a newly identified TSG, has been proposed to take part in the concert of carcinogenesis [1] .
The ING1 gene is localized to chromosome 13q34 and encodes at least 4 protein isoforms (p47 ING1a , p33 ING1b , p24 ING1c , and p27 ING1d ) as a result of the usage of different promoters, exons, and alternative splicing [2] . All of these isoforms share an identical C-terminus containing a plant homeodomain (PHD) zinc finger motif that binds histone H3 in a methylation-sensitive manner to take part in chromatin remodeling, and a nuclear localization signal (NLS) which drives them to enter and reside in the nucleus [1, 2] . Among these variants, p33
ING1b is the most intensively studied and the most extensively expressed isoform in human tissues. Studies have revealed that p33
ING1b is expressed in almost all normal tissues and cells, suggesting a fundamental and pivotal function(s) of p33
ING1b [3] . Apart from the above-mentioned domains, p33
ING1b also harbors three other domains: a proliferating cell nuclear antigen (PCNA) interacting protein motif (PIP) domain which binds PCNA following UV irradiation and is involved in apoptosis and cell cycle arrest, a lamin interaction domain (LID) which binds lamin A/HDAC complex to maintain its levels and biological function in the nucleus, and a partial bromodomain (PBD) which is commonly found in chromatin-associated protein [4] . Recently, it was found that serine 199 of p33
ING1b could be phosphorylated and by this site p33
ING1b could bind to 14-3-3 family proteins, resulting in the translocation of p33
ING1b from the nucleus to the cytoplasm [5] . Studies have demonstrated that p33
ING1b participates in growth regulation, senescence, DNA repair, apoptosis, and angiogenesis [6] . Based on reports of malignancies in the stomach [7] , esophagus [8] , brain [9] , breast [10] , blood [11, 12] , lung [13] , liver [14] , head and neck [15] , lymphoid system [16] , thyroid [17] , and ovary [18] , it can be deduced that the expression of p33
ING1b is often reduced in human malignancies, while mutations in ING1b occur infrequently [19] . Blocking ING1 expression promotes cell proliferation in vitro and tumor formation in vivo [20] . Restoration of p33 ING1b function has been shown to stabilize the malignant phenotype of neoplastic cells. For example, adenovirusmediated ING1b gene transfer significantly suppressed the growth and promoted the apoptosis of glioma cells in vitro [21] .
Although reduced expression of ING1b mRNA has been reported in gastric adenocarcinoma [7] , the role of p33
ING1b in the development and biological behaviors of gastric adenocarcinoma is far from elucidated. In the present study, we firstly confirmed the reduced expression of p33
ING1b in gastric adenocarcinoma tissues and gastric adenocarcinoma cell lines, and then, by using recombinant adenovirus-mediated ectopic expression, we observed the effects of p33
ING1b on proliferation, cell cycle distribution, and apoptosis in gastric adenocarcinoma cells.
Methods

Patients and tissue specimen preparation
Gastric adenocarcinoma samples and their adjacent nonmalignant tissues (at least 2 cm away from the tumor) were collected endoscopically from eight patients at the 1st Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, after obtaining approval from the Institutional Review Boards of Xi'an Jiaotong University, Xi'an. The diagnosis of gastric adenocarcinoma was confirmed histologically. The samples were immediately snap-frozen in liquid nitrogen and stored at -80°C.
Cell culture SGC-7901, MKN28, and MKN45 (gastric adenocarcinoma cell lines), GES-1 (a normal gastric epithelial cell line), and Ad-293 (adenovirus packaging cells) were cultured in Dulbecco's modified Eagle's medium (DMEM; Gibco BRL, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS; Gibco BRL), penicillin (100 U/ml), and streptomycin (100 lg/ml) at 37°C in a humidified CO 2 (5%) atmosphere. Cells were passaged at 1:3 every 3 days.
Western blotting
Gastric tissues and cultured cells were homogenized in RIPA lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1% sodium dodecylsulfate [SDS], 0.02% sodium azide, 1% nonidet P-40, and 0.5% sodium deoxycholate) containing protease inhibitors (100 lg/ml phenylmethanesulfonyl fluoride [PMSF], 1 lg/ml aprotinin), on an ice-bath, followed by centrifugation at 12,000 rpm for 20 min at 4°C. Protein concentration was determined by Bradford assay. Each protein sample (100 lg) was separated on a 10% SDS-polyacrylamide gel (PAGE) and transferred onto a nitrocellulose membrane (Millipore, Bedford, MA, USA). The membrane was blocked with blocking buffer (5% nonfat dry milk and 0.2% Tween-20 in phosphate-buffered saline [PBS] ) and probed with a primary antibody against p33
ING1b (polyclonal antibody prepared in our laboratory by immunizing Balb/c mice with 69 His-tagged N-terminal fragment of human p33
ING1b expressed in Escherichia coli, 1:400 dilution) or b-actin (1:1000 dilution; Sigma, St Louis, MO, USA), followed by incubation with horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG as secondary antibody (1:2,000 dilution; Sigma,). The blots were detected using an enhanced chemiluminescence solution and exposing the membranes to Kodak X-ray film (Kodak, Rochester, NY, USA).
Preparation of recombinant adenoviruses
Recombinant adenovirus (type 5, DE1/E3) carrying ING1b was prepared by using the Adeasy TM Adenovirus Vector System (Stratagene, La Jolla, CA, USA) according to the manufacturer's instructions. Briefly, cDNA of p33
ING1b
was isolated from pCI-ING1b (kindly provided by Dr. K.T. Riabowol, University of Calgary, Canada) by XhoI and SmaI digestion and subcloned into pShuttle-CMV. The recombinant shuttle plasmid pShuttle-CMV-ING1b was linearized by digestion with the restriction endonuclease Pme1 (New England BioLabs, Ipswich, MA, USA) and then transformed into E. coli BJ5183 containing pAdEasy-1, yielding the recombinant adenoviral plasmid pAdING1b. After digestion by PacI (New England Biolabs), the *23-kb fragment of pAd-ING1b was recovered and transfected into Ad-293 cells to produce recombinant adenovirus Ad-ING1b. Aliquots of viral stocks were stored at -80°C until use. Adenovirus expressing green fluorescent protein (Ad-GFP) was also prepared as a control. The viral stocks were titrated on HEK293 cells by a standard protocol just as the manufacturer instructed.
For determination of the appropriate multiplicity of infection (MOI), SGC-7901, MKN28, MKN45, and GES-1 cells were inoculated in 6-well plates and infected with Ad-GFP at MOI of 20, 40, 60, 80, and 100. Seventy-two hours later, the cells were observed under an inverted fluorescence microscope to evaluate the infection efficiency and possible toxic effects.
Cells were inoculated into 96-well micro-culture plates at 1 9 10 3 /well, grown overnight, and infected with Ad-GFP or Ad-ING1b at an MOI of 60. The MTT assay was carried out to assess the number of viable cells before and postinfection, at 24-h intervals. Upon determination, 20 ll MTT was added to each well, followed by incubation at 37°C for 4 h. Then the MTT-containing media was removed and 150 ll dimethylsulfoxide (DMSO) was added to each well. Absorbance at 490 nm was measured using a microplate reader (Bio-Tek Instruments, Winooski, VT, USA). This experiment was performed in triplicate wells and three independent experiments were carried out.
Detection of apoptosis
Apoptosis was determined by flow cytometry (FCM) using an ApoScreen Annexin V-APC kit (Southerbiotech, Birmingham, AL, USA). Cells were seeded into six-well tissue culture plates at a density of 1 9 10 5 cells/well and infected with recombinant adenoviruses at an MOI of 60. To verify whether the effect of p33
ING1b on apoptosis was p53-dependent, a p53 inhibitor, pifithrin-a (PFT-a, SigmaAldrich, St. Louis, MO, USA) was added to MKN-45 and GES-1 cells to reach a final concentration of 20 lmol at the time of infection. Seventy-two hours later, cells were harvested by trypsinization, washed with cooled PBS at 4°C, and centrifuged at 1,500 rpm for 5 min. The pellet was then resuspended in 100 ll binding buffer (10 mM hydroxyethylpiperazine ethanesulfonic acid [HEPES], pH 7.4, 140 mM NaCl, 2.5 mM CaCl 2 , 0.5% bovine serum albumin [BSA] ) and mixed gently with 10 ll of APClabeled Annexin V and 10 ll of propidium iodide (PI). After incubation in the dark at 4°C for 10 min, the sample was mixed with 380 ll 19 binding buffer and vortexed gently. Apoptosis was analyzed in a flow cytometer.
Cell cycle analysis
Twelve hours after the inoculation into 6-well plates, the cells were cultured in DMEM supplemented with 0.2% bovine serum (serum starvation) for 24 h to achieve cell cycle synchronization. Then the cells were infected with adenoviruses and harvested just as in the case of detection of apoptosis. The harvested cells were washed once with ice-cold PBS and fixed with 70% ethanol at 4°C for 12 h. After two washes with ice-cold PBS, the cells were treated with RNase for 30 min and stained with 50 mg/ml of PI. Cell cycle distribution was analyzed in a fluorescenceactivated cell sorter (Becton-Dickinson, Mountain View, CA, USA).
Statistical analysis
Results are presented as means ± standard deviation (M ± SD). Comparisons among means for more than two groups were performed using one-way analysis of variance (ANOVA). Unpaired t-test was used for comparison between two groups. Results were considered statistically significant at P \ 0.05. All analyses were performed using SPSS 13.0 (SPSS Inc., Chicago, IL, USA).
Results
Expression of p33
ING1b was down-regulated in gastric adenocarcinoma tissues and gastric adenocarcinoma cell lines
Western blotting showed that all the paratumor gastric mucosa specimens exhibited p33
ING1b expression. However, gastric adenocarcinoma tissues showed an overall (7 out of 8 specimens) decreased expression level of p33
ING1b compared with paratumor tissues (Fig. 1a) . Just as in the case of the gastric tissue specimens, the expression of p33
ING1b in the three gastric adenocarcinoma cell lines (SGC-7901, MKN28, and MKN45) was lower than that in the normal gastric epithelial cell line, GES-1 (Fig. 1b) . All these results clearly indicate that the expression of p33
ING1b is down-regulated in gastric adenocarcinoma. At an MOI of 60, more than 60% of the cells expressed GFP and atthat time no obvious adenoviral toxicity was observed (Fig. 2a) . Thus subsequently in this study, cells were infected by recombinant adenoviruses at an MOI of 60. Next, Western blotting verified the ectopic expression of p33 ING1b mediated by Ad-ING1b in gastric cells (Fig. 2b) . The above results indicate that adenovirus could efficiently mediate gene transfer and ectopic expression in all the cells used in this study.
Ectopic expression of p33
ING1b inhibited in vitro growth of gastric adenocarcinoma cells and normal gastric epithelial cells
The MTT assay showed that all the four lines of cells infected with Ad-ING1b displayed obviously lower growth rates than their corresponding controls, including the Ad-GFP and PBS groups (Fig. 3) . From day 4 onwards, the numbers of viable cells in the Ad-ING1b groups were significantly lower than those in both the Ad-GFP and PBS groups, while no significant difference in growth rate was observed between the latter two groups. These results indicate that the growth inhibition of Ad-ING1b could be attributed to the ectopic expression of p33 ING1b , and the toxic effect of adenovirus could be excluded.
ING1b induced apoptosis of gastric adenocarcinoma and normal gastric epithelial cells
To define the effect of Ad-ING1b on apoptosis in gastric adenocarcinoma cells and normal gastric epithelia, the cells were analyzed by FCM 72 h after infection. All the cells exhibited a low spontaneous apoptosis rate when treated with PBS. After Ad-GFP infection, the apoptosis rates increased slightly. Infection with Ad-ING1b resulted in a significant increase in apoptosis rates in all the four cell lines. In the Ad-ING1b group, apoptosis rates more than eightfold those in the Ad-GFP and PBS groups were observed. For MKN45 and GES-1 cells, which harbor wild-type p53, no significant difference in apoptosis rates was observed between the Ad-ING1b group and the Ad-ING1b plus PFT-a group (Fig. 4) .
p33
ING1b arrested cell cycle progression at G1 phase in gastric adenocarcinoma and normal gastric epithelial cells
To explore the possible mechanism underlying the growthinhibitory effect of p33 ING1b , the cell cycle distribution in SGC-7901 and GES-1 cells 72 h post-infection was analyzed. Both SGC-7901 and GES-1 cells infected with AdING1b demonstrated a significant increase in cell numbers at the G1 stage compared with those infected with Ad-GFP or uninfected (PBS group) cells (P \ 0.01), while no significant difference was observed in cell cycle distribution between cells infected with Ad-GFP and uninfected cells. In addition, no significant difference in cell cycle distribution was discerned between the Ad-ING1b group and the Ad-ING1b plus PFT-a group in GES-1 cells (Fig. 5) .
Discussion
p33
ING1b has been shown to play an important role in multiple cellular processes such as DNA repair, proliferation, and apoptosis regulation via modulating the transcription of downstream biological molecules [20] . The normal expression level and correct subcellular localization of p33
ING1b is essential for a body or cell to maintain homeostasis. Downregulated expression, mutation, or mislocalization of p33
ING1b leads to the uncontrolled growth of cells and is involved in carcinogenesis [20] . Reduced p33
ING1b expression, regardless of whether it occurs via mutation or mislocalization, is present in many cancers. A previous study showed reduced expression of ING1b mRNA in gastric adenocarcinoma, suggesting that down-regulation of ING1b might participate in gastric carcinogenesis [7] . However, the expression of p 33ING1b at the protein level has not been reported. In the present study, we detected the expression of p33
ING1b in gastric adenocarcinoma specimens and gastric cancer cell lines by using Western blotting. The results showed that the expression of p33
ING1b in gastric carcinoma tissues was obviously reduced compared with that in their paired paratumor gastric mucosa. Also, p33
ING1b expression was down-regulated in the gastric adenocarcinoma cell lines SGC-7901, MKN28, and MKN45 compared with the normal by nucleus-to-cytoplasm translocation in cancer cells [11, 22] . Based on these results, it can be concluded that decreased expression of p33 ING1b is a common phenomenon in gastric adenocarcinoma, and this alteration might contribute to the development of gastric adenocarcinoma. ING1b on the proliferation, apoptosis, and cell cycle distribution of gastric adenocarcinoma and normal gastric epithelial cells. To guarantee the efficiency of gene transfer, we prepared recombinant adenovirus to mediate the expression of ING1b. The results showed that the ectopic expression of p33
ING1b induced growth retardation, cell cycle arrest at the G1 phase, and, especially, apoptosis, in both the malignant and normal gastric epithelial cells in vitro. Our present results are supported by the previous studies in which p33
ING1b exhibited proliferation-inhibitory, apoptosis-promoting, and cell cycle-arrest effects in both benign and malignant cells [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] . These data, along with the results of reduced expression of p33 ING1b in gastric adenocarcinoma tissues, provide substantial evidence that p33
ING1b acts as a negative regulator in the development of gastric adenocarcinoma. p33 ING1b was formerly considered to exert its biological functions through physical and functional interaction with p53 [21, 28, 29] . Recently, some studies demonstrated that p33
ING1b could function in a p53-independent manner [25, 30, 31] . Our present results revealed that p33
ING1b could induce growth retardation, apoptosis, and cell cycle arrest in both p53 wild-type (MKN45, GES-1) and p53 mutant (MKN28, SGC-7901) cells. Furthermore, for p53 wild-type cells, the addition of the p53 inhibitor pifithrin-a did not abolish the pro-apoptosis and cell cycle-arrest effects of p33 ING1b . These results suggest that the pro-apoptosis and anti-proliferation effects of p33
ING1b are, at least partly, independent of p53.
To our knowledge, this is the first study to have explored the possible role and mechanisms of p33
ING1b in the biological behaviors of gastric carcinoma. Our results confirmed the down-regulated expression of p33
ING1b in human gastric adenocarcinoma and demonstrated the antiproliferation and pro-apoptosis effects of Ad-ING1b in human gastric adenocarcinoma cells regardless of their p53 status. These results suggest that targeted local administration of Ad-ING1b might be considered as a promising therapeutic measure for gastric adenocarcinoma. ING1b is down-regulated in gastric carcinoma tissues and gastric adenocarcinoma cell lines. Adenovirus-mediated ectopic expression of p33
ING1b suppresses proliferation and induces apoptosis in gastric adenocarcinoma cells p33
ING1b on gastric cancer cells 361
